Llewelyn Linda 4

4 · Health Catalyst, Inc. · Filed Feb 27, 2026

AI-generated summary of this filing

Updated Feb 27, 2026

Health Catalyst CPO Linda Llewelyn Receives RSU Awards, Sells 4,471 Shares

What Happened

Linda Llewelyn, Chief People Officer of Health Catalyst (HCAT), was granted a total of 204,695 equity units on Feb 25, 2026: 191,500 restricted stock units (RSUs) and 13,195 performance-based RSUs (PRSUs). Both awards were granted at no cash cost (price reported $0.00).
On Feb 26, 2026, 4,471 shares were disposed at $1.75 per share (proceeds ≈ $7,814). That sale was a mandatory "sell to cover" to satisfy tax-withholding obligations tied to the RSU vesting, not a discretionary open-market sale.

Key Details

Transaction dates: Grants on 2026-02-25; sell-to-cover on 2026-02-26. Form 4 filed 2026-02-27 (appears timely).
Award amounts: 191,500 RSUs (F1) + 13,195 PRSUs (F2) = 204,695 units granted. Grant price: $0.00.
Sale: 4,471 shares at $1.75 each; proceeds ≈ $7,814. Classified as tax withholding (F3), not a voluntary sale.
Vesting: RSUs vest in 12 equal quarterly installments beginning March 1, 2026 (per F1). PRSUs vest based on performance for fiscal year ended Dec 31, 2025 (per F2).
Shares owned after the transaction: not reported in the information provided.
Filing/accession: Period of report 2026-02-25; Accession No. 0001780878-26-000001.

Context

RSUs and PRSUs are contingent awards that convert into shares only if vesting conditions are met; grants themselves are not purchases and do not represent an immediate cash investment by the insider.
The small sale was mandated by the company’s sell-to-cover tax withholding policy (common practice) and should not be interpreted as a discretionary signal of sentiment.

Form 4

Period: 2026-02-25

Chief People Officer

Transactions

Footnotes (3)

[F1]Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will vest in 12 equal quarterly installments beginning on March 1st 2026.
[F2]Represents an award of 13,195 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Each PRSU represents a contingent right to receive one share of the Issuer's common stock.
[F3]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Signature

/s/Benjamin Landry, as Attorney-in-Fact|2026-02-27

1 file